Skip to content

Exudative Vitreoretinopathy 4 Autosomal Recessive C4016839

Published: July 22, 2026Updated: August 20, 2026

A recessive genetic form of retinal vessel abnormality that may lead to retinal detachment. Management includes regular eye exams and surgery.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden vision loss

!

Photopsia

!

Vitreous hemorrhage

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Floaters

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-VEGF intravitreal therapy

Intravitreal injection of vascular endothelial growth factor inhibitors to reduce abnormal retinal vessel proliferation and leakage associated with exudative changes.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Laser photocoagulation

Argon or diode laser application to ischemic retinal areas to reduce VEGF production and prevent progression of neovascularization.

procedure

Additional treatment options

Vitrectomy with membrane peeling

Surgical removal of vitreous gel and tractional membranes to relieve retinal detachment and improve visual outcomes in advanced cases.

surgical

Structured ophthalmologic surveillance

Regular comprehensive eye examinations including optical coherence tomography and fluorescein angiography to detect disease progression and treatment response.

monitoring

Genetic counseling and family screening

Comprehensive genetic evaluation and counseling for affected families to understand inheritance patterns and identify at-risk relatives for early intervention.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Exudative Vitreoretinopathy 4 Autosomal Recessive C4016839?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Exudative Vitreoretinopathy 4 Autosomal Recessive C4016839. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy